Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 15066 publications
2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,200.00

This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 122 pages
2014-2018 UK Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Spain Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Japan Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Italy Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 Germany Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 France Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 3,000.00

This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 121 pages
2014-2018 European Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 4,200.00

This unique report from Venture Planning Group provides Europe sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing ...

Nov, 2014 129 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers US$ 4,850.00

This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, ...

Nov, 2014 134 pages
2014-2018 UK Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic... US$ 6,700.00

... of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, ...

Nov, 2014 855 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 32,200.00

... major suppliers of molecular diagnostic reagent kits and components. Five-year test volume and sales forecasts for major applications, including: Infectious ... HLA Typing Genetic Diseases Others Five-year test volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing ...

Nov, 2014 1050 pages
2014-2018 Spanish Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including: issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ...

Nov, 2014 850 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

The report presents insightful analyses of major current and emerging suppliers of molecular diagnostic products in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 120 pages

Nov, 2014 120 pages
2014-2018 Japanese Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 8,500.00

This new 860-page report from Venture Planning Group contains 36 tables, and presents a comprehensive analysis of the Japanese molecular diagnostics market, including: issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and ...

Nov, 2014 860 pages
2014-2018 Italian Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the Italian molecular diagnostics market, including: issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ...

Nov, 2014 850 pages
2014-2018 German Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the German molecular diagnostics market, including: issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...

Nov, 2014 850 pages
2014-2018 French Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 6,700.00

This report presents a comprehensive analysis of the French molecular diagnostics market, including: issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...

Nov, 2014 850 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Facilities, Test Volumes, and Sales Forecasts by Country US$ 2,450.00

... provides: Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country. Five-year test volume and sales forecasts by country. Contains 15 pages and 4 tables

Nov, 2014 15 pages
2014-2018 US Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer, Forensic... US$ 9,500.00

... of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, ...

Nov, 2014 880 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Emerging Technologies and Strategic Profiles of Leading Suppliers US$ 3,500.00

This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other. The report also presents ...

Nov, 2014 180 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Latest Instrumentation and Strategic Profiles of Leading Suppliers US$ 3,500.00

This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA ...

Nov, 2014 103 pages
2014-2018 World Nucleic Acid Testing/NAT Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers US$ 3,500.00

... provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of molecular ...

Nov, 2014 109 pages
2014-2018 European Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Infectious Diseases, Genetic Diseases, Cancer,... US$ 19,700.00

... entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The ... business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares ...

Nov, 2014 970 pages
2014-2018 US Drugs of Abuse Decentralized/POC Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers - Supplier Shares, Sales Forecasts, Emerging Technologies,... US$ 2,500.00

... Group contains 14 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory ... . Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency ...

Nov, 2014 165 pages
2015 U.S. Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores-Product & Retail Report, published ... on the sales of Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores nationally and for all 50 U.S. States and ...

Nov, 2014 96 pages
2015 U.S. Drugs, health aids, beauty aids sold through Pharmacies & drug stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Pharmacies & drug stores-Product & Retail Report, published annually by Barnes Reports, contains ... estimates on the sales of Drugs, health aids, beauty aids sold through Pharmacies & drug stores nationally and for all 50 U.S. States and up to 900 metro ...

Nov, 2014 96 pages
2015 U.S. Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores-Product & Retail Report, published annually by Barnes ... on the sales of Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores nationally and for all 50 U.S. States and up to 900 ...

Nov, 2014 96 pages
2015 U.S. Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores-Product & Retail Report US$ 199.00

The 2015 U.S. Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores-Product & Retail Report, published annually by Barnes Reports, ... 2016 forecast estimates on the sales of Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores nationally and for all 50 U.S. States and up to ...

Nov, 2014 94 pages
Clinical Trials US$ 1,000.00

... Management Consultancy S.A. and aims to reflect the current state of the Clinical Trials in Greece and to examine its prospects, while presenting information ... research The Greek businesses of the sector usually take over clinical studies from multinational pharmaceutical companies or are sub-contracting from ...

Sep, 2014
Vitamins China E-News 1410 US$ 3,564.00

... vitamin market. Affected by the increasing demand of overseas market, China’s VC export volume rises by 12% year on year in Jan.-Aug. 2014. And VE increases by 20%. As for ... of concern for the domestic vitamin industry. As the largest VD3 manufacturer in China, Garden Bio-chemical benefits from the price rise ...

Oct, 2014 33 pages
Vitamin Trade Flows in China/industry publications US$ 2,160.00

... a direct analyse of China's vitamin trade flows around the volume, price, partners, and an indirect description of industry changes. What to report: In this report, import and export of China's vitamins in 2013 and H1 2014 are analyzed in the following aspects: Trade volume and value of ...

Oct, 2014 58 pages
Pharmaceutical Industry in China/industry publications US$ 14,040.00

... of China’s pharmaceutical industry; Report topics: Relevant government regulations Key suppliers Mergers & acquisitions cases Technology R&D Drug pricing reform Pharmacy trusteeship Industry forecast: China’s pharmaceutical industry has developed rapidly during 2006-2013, attaining a CAGR of ...

Oct, 2014 65 pages
2014 Deep Research Report on Global Human Albumin Industry US$ 3,600.00

2014 Deep Research Report on Global Human Albumin Industry> was professional and depth research report on Global Human Albumin industry. The report firstly introduced Human Albumin basic information included Human Albumin definition classification application industry chain structure industry overview; ...

Nov, 2014 149 pages
Zedira GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Zedira GmbH’s pipeline products ... new drug targets and therapeutic classes in the Zedira GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 27 pages
VTT Technical Research Centre of Finland - Product Pipeline Review - 2014 US$ 1,500.00

... of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the VTT Technical Research Centre of Finland’s pipeline ...

Nov, 2014 17 pages
uniQure NV - Product Pipeline Review - 2014 US$ 1,500.00

... Summary Global Markets Direct’s, ‘uniQure BV - Product Pipeline Review - 2014’, provides an overview of the uniQure BV’s pharmaceutical research and development focus. This ... type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued ...

Nov, 2014 35 pages
Sinil Pharmaceutical Co., Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Sinil Pharmaceutical Co., Ltd’s pipeline products Reasons ... Assess the growth potential of Sinil Pharmaceutical Co., Ltd in its therapy areas of focus Identify new drug targets and therapeutic classes in the ...

Nov, 2014 17 pages
Retrophin Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Retrophin, LLC’s pipeline products ... drug targets and therapeutic classes in the Retrophin, LLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 35 pages
Paras Biopharmaceuticals Finland Oy - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Paras Biopharmaceuticals Finland Oy’s pipeline products Reasons ...

Nov, 2014 24 pages
Otonomy, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Otonomy, Inc.’s pipeline products ... drug targets and therapeutic classes in the Otonomy, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 26 pages
Nuvilex, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Nuvilex, Inc.’s pipeline products ... drug targets and therapeutic classes in the Nuvilex, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 21 pages
Merz Pharmaceuticals GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Merz Pharmaceuticals GmbH’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Merz Pharmaceuticals GmbH’s pipeline products Reasons to ...

Nov, 2014 24 pages
Lateral Epicondylitis (Tennis Elbow) - Pipeline Review, H2 2014 US$ 2,000.00

... , H2 2014’, provides an overview of the Lateral Epicondylitis(Tennis Elbow)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... for Lateral Epicondylitis(Tennis Elbow) and enlists all their major and minor projects The report summarizes all the dormant ...

Nov, 2014 41 pages
Laila Pharmaceuticals Pvt. Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Laila Pharmaceuticals Pvt. Ltd. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Laila Pharmaceuticals Pvt. Ltd.’s pipeline products ...

Nov, 2014 29 pages
Delpor, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Delpor, Inc.’s pipeline products ... drug targets and therapeutic classes in the Delpor, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 21 pages
Ascepion Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Ascepion Pharmaceuticals, Inc.’s pipeline products Reasons to ...

Nov, 2014 20 pages
Ariad Pharmaceuticals, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of Ariad Pharmaceuticals, Inc.’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Ariad Pharmaceuticals, Inc.’s pipeline products Reasons ...

Nov, 2014 45 pages
Aposense Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Aposense Ltd.’s pipeline products ... drug targets and therapeutic classes in the Aposense Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Nov, 2014 19 pages
ACROVIS biostructures GmbH - Product Pipeline Review - 2014 US$ 1,500.00

... , key information and facts, and its locations and subsidiaries The report reviews current pipeline of ACROVIS biostructures GmbH’s human therapeutic ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the ACROVIS biostructures GmbH’s pipeline products Reasons ...

Nov, 2014 16 pages
Abera Bioscience AB - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Abera Bioscience AB’s human therapeutic ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Abera Bioscience AB’s pipeline products ...

Nov, 2014 18 pages
1 2 3 4 5 >
Skip to top